Biotech & MedTech News
-
StageZero Life Sciences Adds BreastSentry and Prostate Health Index to Licensing and Services Agreement with Oncore Pharma
December 9, 2019 (Source) – StageZero Life Sciences, Limited (TSX:SZLS) (”StageZero” or the ”Company”), a life sciences company specializing…
-
Nova Leap Health Corp. Announces Non-Brokered Private Placement of Convertible Debentures
December 5, 2019 (Source) – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or the “Company”), a 2019 TSX…
-
StageZero Life Sciences Announces Q3 2019 Progress Update
November 15, 2019 (Source) – StageZero Life Sciences, Ltd (TSX:SZLS) (”StageZero” or the ”Company”) today announced operational results for…
-
StageZero Life Sciences Expands Telehealth Presence With the Addition of New Partners Including an e-Commerce Platform and Expansion of In-Home Mobile Phlebotomy
November 14, 2019 (Source) – StageZero Life Sciences Ltd (TSX:SZLS) (“StageZero” or the “Company”) announced today that it continues to…
-
StageZero Announces 3rd Quarter 2019 Investor Call
November 13, 2019 (Source) – StageZero Life Sciences (“StageZero” or the “Company”) (TSX:SZLS) today announced that it will release…
-
Nova Leap Health Corp. Posts Record Financial Results for Third Quarter 2019
November 7, 2019 (Source) – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 TSX…
-
StageZero Life Sciences Makes ColonSentry(R) Blood Test Available to Consumers Through Online Telehealth Platform
November 6, 2019 (Source) – ColonSentry® is One of the First Blood Tests to Aid in The Early Identification…
-
Nova Leap Health Corp. Completes Purchase of Massachusetts Home Care Business
November 4, 2019 (Source) – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 TSX…
-
StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL: Update to Clarify Details Within the Agreement
October 21, 2019 (Source) – StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”), a life sciences company dedicated…
-
StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL; Multi-Year Agreement Valued at US$40 million
October 10, 2019 (Source) – StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”), a life sciences company dedicated…
